Ads
related to: baxter healthcare products
Search results
Decoding Baxter International Inc (BAX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 months agoComprehensive SWOT analysis based on Baxter International Inc's latest SEC 10-K filing. Strategic...
3 Reasons to Retain Baxter (BAX) Stock in Your Portfolio
Zacks via Yahoo Finance· 2 years agoBaxter International Inc. BAX is well poised for growth in the coming quarters, backed by a strong...
Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio
Zacks via Yahoo Finance· 2 months agoBaxter (BAX) unveils its five injectable products, which strengthen its emphasis on unique products...
Baxter (BAX) Beats on Q2 Earnings, Revises 2023 EPS Guidance
Zacks via Yahoo Finance· 10 months agoBaxter's (BAX) second-quarter 2023 results reflect sustained demand for its medically essential...
Baxter's (BAX) Latest FDA Approval to Boost Infusion Therapy
Zacks via Yahoo Finance· 2 months agoBaxter International Inc. BAX recently received the FDA’s 510(k) clearance for its Novum IQ large...
Baxter (BAX) Novum IQ SYR's FDA Clearance Boosts Patient Care
Zacks via Yahoo Finance· 2 years agoBaxter International Inc. BAX recently announced the receipt of the FDA’s 510(k) clearance for its...
Baxter (BAX) Q1 Earnings Beat Estimates, '24 EPS View Raised
Zacks via Yahoo Finance· 1 month agoBaxter (BAX) reports better-than-expected first-quarter earnings and sales. BAX's quarterly results...
Baxter to close Massachusetts site, lay off 59 people
MedTech Dive via Yahoo Finance· 3 months agoDive Brief: Baxter International will close its manufacturing operations in Acton, Massachusetts,...
Baxter (BAX) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 4 months agoBaxter's (BAX) fourth-quarter results are likely to reflect growth in elective surgical procedures,...
Baxter's (BAX) New Premix Drug Now Available in the U.S.
Zacks via Yahoo Finance· 1 year agoBaxter's (BAX) latest frozen premix formulation is expected to support patient safety, simplify...
